Hdac11 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Histone Deacetylase 11 | |
|---|---|
| Gene Symbol | HDAC11 |
| Full Name | Histone Deacetylase 11 |
| Chromosome | 3p25.2 |
| NCBI Gene ID | 79868 |
| OMIM | 608593 |
| Ensembl ID | ENSG00000141329 |
| UniProt ID | Q9UKV0 |
| Associated Diseases | Cancer, Autoimmune Disorders, Neurodegeneration |
HDAC11 (Histone Deacetylase 11) is the sole member of the class IV histone deacetylase family, distinguished by its unique structure and tissue-specific expression patterns. HDAC11 is highly expressed in brain, kidney, heart, and skeletal muscle, with particular enrichment in neuronal populations. It regulates gene expression through histone deacetylation and interacts with various transcription factors and co-regulators. HDAC11 plays important roles in immune regulation, metabolism, and neuronal function.
In neurodegenerative diseases, HDAC11 has been implicated in regulating neuroinflammatory responses and neuronal survival pathways. The enzyme influences the expression of cytokines, chemokines, and immune receptors in microglia, contributing to the chronic neuroinflammation characteristic of Alzheimer's and Parkinson's diseases. HDAC11 represents an emerging therapeutic target with potential for modulating immune responses in neurodegeneration.
HDAC11 encodes histone deacetylase 11, the sole class IV HDAC. HDAC11 is the smallest HDAC and has unique structural features distinguishing it from class I, II, and III enzymes. It is expressed in brain, heart, muscle, and kidney. HDAC11 regulates gene expression, immune responses, and metabolism. In the brain, HDAC11 may regulate neuronal gene expression and immune responses in glial cells. It is emerging as a potential therapeutic target in cancer and inflammatory diseases.
Tissue-specific expression with high levels in brain, heart, and skeletal muscle. Nuclear localization in neurons and other cell types.
| Disease | Variants | Inheritance | Mechanism |
|---|---|---|---|
| Cancer | Overexpression | Oncogene | Altered gene expression |
| Autoimmune disorders | Variants | Risk factor | Immune dysregulation |
| Neurodegeneration | Variants | Risk factor | Altered neuronal function |
The study of Hdac11 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.